MedPath

Penequinine, Penehyclidine

Generic Name
Penequinine, Penehyclidine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C20H29NO2
CAS Number
87827-02-9
Unique Ingredient Identifier
353CX8CSHD
Background

Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).

Indication

⑴麻醉前给药以抑制涎腺和气道腺体分泌。

⑵用于有机磷毒物中毒急救治疗和中毒后期或胆碱酯酶老化后维持阿托品化。但单独应用疗效差,应与酶重活化剂联合应用。

Associated Conditions
-
Associated Therapies
-
nature.com
·

Low blood S-methyl-5-thioadenosine is associated with postoperative delayed ...

C57BL/J6 male mice were used for metabolomics and isotope-labeled MTA analysis under anesthesia. MTA was injected to examine blood–brain barrier crossing. Surgery experiments exposed the left carotid artery, and MTA rescue experiments were conducted. Metabolomics processing involved LC-MS/MS, PCA, PLS-DA, and OPLS-DA. snRNA-seq libraries were generated for single-cell analysis. Joint pathway analysis used O2PLS and MetaboAnalyst 5.0. Western blotting and ELISA assessed protein and cytokine levels. Behavioral tests included open field and Barnes maze tests. A clinical investigation evaluated cognitive decline post-surgery in humans, with serum samples analyzed by LC-MS/MS. Statistical methods included Student’s t-test, ANOVA, and ROC curve analysis.
© Copyright 2025. All Rights Reserved by MedPath